Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-02

Clinical Trial Update: Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome. [NA]

View source ↗

Summary

A completed clinical trial comparing T2769 to Hylo-Forte for moderate to severe dry eye syndrome, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hylo-Forte (sodium hyaluronate)
  • T2769

Snippet

Sponsor: Laboratoires Thea | Conditions: Dry Eye Syndrome | NA | Status: COMPLETED | Results posted: 2026-01-02